3.4.21.27	additional information	-	additional information	-	683682	
3.4.21.27	additional information	-	additional information	competition for platelet binding by the wild-type enzyme and mutants, overview	683160	
3.4.21.27	additional information	-	additional information	second-order inhibition rate constants, wild-type and mutant enzymes with different inhibitors, overview	683157	
3.4.21.27	0.00000002	-	methyl [(11S)-11-([(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl]amino)-6-fluoro-2-oxo-1,3,4,10,11,13-hexahydro-2H-5,9:15,12-di(azeno)-1,13-benzodiazacycloheptadecin-18-yl]carbamate	at 37°C, pH not specified in the publication	752995	
3.4.21.27	0.0000002	-	3'-[(2S,4R)-6-carbamimidoyl-4-methyl-4-phenyl-1,2,3,4-tetrahydroquinolin-2-yl]-4-carbamoyl-5'-[(3-methylbutanoyl)amino]biphenyl-2-carboxylic acid	at pH 7.4 and 37°C	732318	
3.4.21.27	0.0000003	-	trans-N-((S)-1-(4-(3-amino-1H-indazol-6-yl)-5-fluoro-1H-imidazol-2-yl)-2-phenylethyl)-4-(aminomethyl)cyclohexanecarboxamide	at pH 7.4 and 37°C	732318	
3.4.21.27	0.00000031	-	trans-N-[(1S)-1-[4-(3-amino-1H-indazol-6-yl)-5-chloro-1H-imidazol-2-yl]-2-phenylethyl]-4-(aminomethyl)cyclohexanecarboxamide	at 25°C, pH not specified in the publication	731462	
3.4.21.27	0.00000031	-	trans-N-[(1S)-1-[4-(3-amino-1H-indazol-6-yl)-5-chloro-1H-imidazol-2-yl]-2-phenylethyl]-4-(aminomethyl)cyclohexanecarboxamide	pH and temperature not specified in the publication	731466	
3.4.21.27	0.00000032	-	methyl [(11S)-11-([(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl]amino)-2-oxo-1,3,4,10,11,13-hexahydro-2H-5,9:15,12-di(azeno)-1,13-benzodiazacycloheptadecin-18-yl]carbamate	at 37°C, pH not specified in the publication	752995	
3.4.21.27	0.00000053	-	methyl [(11S)-11-([(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl]amino)-6-fluoro-2-oxo-1,3,4,10,11,13-hexahydro-2H-15,12-(azeno)-5,9-(metheno)-1,13-benzodiazacycloheptadecin-18-yl]carbamate	at 37°C, pH not specified in the publication	752995